Renal insufficiency

ESH eLearning, Stefan Knop, 38704

Frailty

ESH eLearning, Alessandra Larocca, 38706

Bone disease

ESH eLearning, Evangelos TERPOS, 38722

Clinical conditions - Side effects

ESH eLearning, Heinz Ludwig, 38709

Imaging

ESH eLearning, Evangelos TERPOS, 38723

New tools for response assessment and prognostic value of CR

ESH eLearning, Bruno Paiva, 38717

Prognostic of cytogenetic abnormalities

ESH eLearning, Hervé Avet-Loiseau, 38698

CRAB and staging

ESH eLearning, Philippe Moreau, 38712

Whole genome sequence

ESH eLearning, Nikhil Munshi, 38715

SNIP and CGH arrays

ESH eLearning, Faith Davies, 38700

Gene expression profiling and miRNA

ESH eLearning, Alberto Rocci, 38719

Welcome address

ESH eLearning, Paul Browne, 39325

Wrap-up of new molecular findings in MDS - time for a new classification?

ESH eLearning, Mario Cazzola, 21313

SCT - decision-making for very high-risk and elderly patients

ESH eLearning, lionel Adès, 21312

Hypomethylating agents in best clinical practice

ESH eLearning, lionel Adès, 21310

How to treat thrombocytopenia and autoimmune features?

ESH eLearning, A Ganser, 21308

Combination drug therapy

ESH eLearning, Guillermo Garcia-Manero, 21307

New experimental drugs

ESH eLearning, Guillermo Garcia-Manero, 21306

New molecular and biological targets for treatment

ESH eLearning, Alan List, 21305

Risk evaluation and treatment

ESH eLearning, Pierre Fenaux, 21304

Juvenile myelomonocytic leunited kingdomemia

ESH eLearning, Charolotte Niemeyer, 21303

Adult CMML: clinical features and treatment

ESH eLearning, DT Bowen, 21302

Spliceosome mutations in different subtypes of MDS

ESH eLearning, Seishi Ogawa, 21300

Clinical features and prognosis

ESH eLearning, Eva Hellstrom-Lindberg, 21299

SF3B1 mutations in MDS with ring sideroblasts

ESH eLearning, Mario Cazzola, 21298

Discussion

ESH eLearning, Ghulam Mufti, 21319

Biology of anaemia and disease progression

ESH eLearning, Jacqueline Boultwood, 21295

Therapeutic recommendations in low- and high-risk MDS

ESH eLearning, Theo De Witte, 21293

Allogeneic stem cell transplantation

ESH eLearning, Nicolaus Kröger, 21291

Hypomethylating agents and chemotherapy

ESH eLearning, Pierre Fenaux, 21290

Immunosuppressive therapy and immunoregulatory drugs (IMiDS)

ESH eLearning, A Ganser, 21289

Transfusion therapy and erythropoiesis-stimulating agents (ESAs)

ESH eLearning, Arjan van de Loosdrecht, 21288

Clinical evaluation and risk assessment in children and young adults

ESH eLearning, Charolotte Niemeyer, 21287

Less common clinical features in MDS

ESH eLearning, Eva Hellstrom-Lindberg, 21285

Clinical presentation including data from the EUMDS Registry

ESH eLearning, Theo De Witte, 21284

Cytogenetics and molecular genetics in clinical practice

ESH eLearning, Brigitte Schlegelberger, 21282

Immunophenotyping

ESH eLearning, Arjan van de Loosdrecht, 21281

Role of morphology in 2012

ESH eLearning, Anna Porwit, 21280

MDS stem and progenitor cell biology

ESH eLearning, Petter S. Woll, 21279

Deciphering myelodysplastic genome

ESH eLearning, Joop Jansen, 21276

Incidence of MDS and environmental factors

ESH eLearning, DT Bowen, 21274

Chapter 24 - Ethics of research and clinical practice

ESH eLearning, Cliff Chaplin, 165709

Chapter 23 - Cell therapy for tissue regeneration/repair

ESH eLearning, Eliane Gluckman Marie Caroline Le Bousse-Kerdi, 165708

Chapter 22 - Methodology of conducting academic clinical trials in Europe

ESH eLearning, M Mohty, 165707

Chapter 21 - Statistical evaluation of HSCT data

ESH eLearning, Richard Richard, 165706

Chapter 20.10 - High-dose chemotherapy and HSCT in children and adolescents with solid tumours in Europe

ESH eLearning, Ruth Ladenstein and Ulrike Pötschger, 165705

Chapter 20.9 - Haemoglobinopathies

ESH eLearning, Emanuele Angelucci and Donatella Baronciani, 165704

Chapter 20.8 - Hereditary bone marrow failure syndromes

ESH eLearning, eliane Gluckman, 165703

Chapter 20.7 - HSCT in inborn errors of metabolism and osteopetrosis

ESH eLearning, Jaap J. Boelens, Marc Bierings Robert Wynn, 165702

Chapter 20.6 - Primary immunodeficiency diseases

ESH eLearning, Paul Veys and H. Bobby Gaspar, 165701

Chapter 20.5 - HSCT for lymphomas in children and adolescents

ESH eLearning, Franco Claviez, 165700

Chapter 20.4 - Chronic myeloproliferative disorders: The role of HSCT in childhood MPD

ESH eLearning, Franco Locatelli and Charlotte M. Niemeyer, 165699

Chapter 20.3 - HSCT in children with myelodysplastic syndromes

ESH eLearning, Franco Locatelli Alice Bertaina, Giuseppe Palum, 165698

Chapter 20.2 -Acute lymphoblastic leukaemia in children and adolescents

ESH eLearning, Christina Peters, 165697

Chapter 20.1 - Acute myeloid leukaemia

ESH eLearning, Giorgio Dini and Stefano Giardino, 165696

Chapter 19.12 - Aplastic anaemia and paroxysmal nocturnal haemoglobinuria

ESH eLearning, Judith Marsh, 165695

Chapter 19.11 - Autoimmune diseases

ESH eLearning, John A. Snowden, Riccardo Sacc Dominique Farge, 165694

Chapter 19.10 - Solid tumours in adults

ESH eLearning, Marco Bregni, 165693

Chapter 19.9 - HSCT for Hodgkin’s lymphoma in adults

ESH eLearning, Anna Sureda and Harry C. Schouten, 165692

Chapter 19.8 - HSCT for non-Hodgkin’s lymphoma

ESH eLearning, Harry C. Schouten and Anna Sureda, 165691

Chapter 19.7 - Role of HSCT in primary amyloidosis

ESH eLearning, M. Teresa Cibeira and Jordi Esteve, 165690

Chapter 19.6 - Multiple myeloma

ESH eLearning, Jesús San-Miguel, José A. Pére M. Victoria Mateos, 165689

Chapter 19.5 - Chronic lymphocytic leukaemia

ESH eLearning, Peter Dreger and Johannes Schetelig, 165688

Chapter 19.4 - Chronic myeloid leukaemia and the myeloproliferative disorders

ESH eLearning, Jiri Pavlu and Jane Apperley, 165687

Chapter 19.3 - HSCT for myelodysplastic syndromes

ESH eLearning, Nicolaus Kröger, 165686

Chapter 19.2 - Acute lymphoblastic leukaemia

ESH eLearning, M Mohty, 165685

Chapter 19.1 - Acute myeloid leukaemia

ESH eLearning, M Mohty, 165684

Chapter 18 - Indications for and current practice of allogeneic and autologous HSCT

ESH eLearning, Alois Gratwohl, Helen Baldomer Anna Sureda, 165683

Chapter 17 – Immunotherapy post-transplant

ESH eLearning, Inge Jedema and J.H. Frederik Falkenburg, 165682

Chapter 16.2 - Chimerism

ESH eLearning, Thomas Lion, 165681

Chapter 16.1 - Molecular monitoring of minimal residual disease

ESH eLearning, Jean-Michel Cayuela, 165680

Chapter 15 - Late effects in patients treated with HSCT

ESH eLearning, Andre Tichelli, 165679

Chapter 14 - Immune reconstitution after allogeneic HSCT

ESH eLearning, Antoine Toubert, 165678

Chapter 13 - Graft-versus-host disease

ESH eLearning, Jane Apperley and Tamas Masszi, 165677

Chapter 12 - Infections after HSCT

ESH eLearning, Montserrat Rovira, Josep Mensa Enric Carreras, 165676

Chapter 11 - Early complications after HSCT

ESH eLearning, Enric Carreras, 165675

Chapter 10 - Supportive care

ESH eLearning, Tamas Masszi and Arno Mank, 165674

Chapter 9 - Transfusion support in patients undergoing HSCT

ESH eLearning, Rachel Pawson and Derwood Pamphilon, 165673

Chapter 8 - Principles of conditioning

ESH eLearning, Alois Gratwohl and Enric Carreras, 165672

Chapter 7 - Bone marrow donor registries and cord blood banks

ESH eLearning, Carlheinz Mueller and Sergio Querol, 165671

Chapter 6 - Choice of the donor according to HLA typing and stem cell source

ESH eLearning, eliane Gluckman, 165670

Chapter 5 - Immunogenetics of allogeneic HSCT

ESH eLearning, Bronwen E. Shaw Alejandro Madrigal, 165669

Chapter 4 - Biological properties of haematopoietic stem cells

ESH eLearning, Aleksandra Wodnar-Filipowicz, 165668

Chapter 3 - JACIE & quality management in HSCT

ESH eLearning, Christian Chabannon Eoin McGrath, 165667

Chapter 2 - Present and future

ESH eLearning, Alejandro Madrigal Anna Sureda, 165666

Chapter 1 - A brief history of HSCT

ESH eLearning, eliane Gluckman, 165665

Cord blood transplant and very rare anaemias

ESH eLearning, Annalisa Ruggeri, 17976

Quality controls for the diagnosis of rare red cell disorders

ESH eLearning, Andrea Mosca, 17974

Paroxysmal Nocturnal Haemoglobinuria

ESH eLearning, Regis Peffault de Latour, 17973

Microangiopathic haemolytic anaemias - TTP, HUS ( haemolytic uraemic syndrome)

ESH eLearning, Paul Coppo, 17972

Autoimmune haemolytic anaemias by warm antibodies

ESH eLearning, Norbert Ahrens, 17970

Cold-antibody mediated autoimmune hemolytic anemia

ESH eLearning, Sigbjorn Berentsen, 17971

Clinical case 3

ESH eLearning, Joan-LLuis Vives-Corrons, 17969

Clinical case 2

ESH eLearning, A. A. M. Ermens, 19900

Clinical Case 1

ESH eLearning, R van Wijk, 19899

Normal and defective red blood cell metabolism abnormalities of glycolysis and the generation of reduced glutathione

ESH eLearning, R van Wijk, 17968

Closing talk of Day 1

ESH eLearning, Joan-LLuis Vives-Corrons, 17967

Erythropoietic porphyrias

ESH eLearning, Jean Charles Deybach, 17966

Clinical cases of membrane disorders

ESH eLearning, Alberto Zanella & Leticia Ribeiro, 19868

Hereditary elliptocytosis, pyropoikilocytosis and South-East Asian Ovalocytosis

ESH eLearning, Leticia Ribeiro, 17963